期刊簡介 | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | PLoS Pathogens LetPub Score 7.3
51 ratings
Rate
Reputation 8.1 Influence 6.8 Speed 6.9 | ||||||||||||||||||||||||||||||||||||
期刊簡稱 | PLOS PATHOG | ||||||||||||||||||||||||||||||||||||
ISSN | 1553-7374 | ||||||||||||||||||||||||||||||||||||
h-index | 154 | ||||||||||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||||||||||
自引率 (2023-2024) | 3.60%自引率趨勢 | ||||||||||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||||||||||
官方網站 | http://journals.plos.org/plospathogens/ | ||||||||||||||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/PPATHOGENS | ||||||||||||||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||||||||||||||
出版商 | Public Library of Science | ||||||||||||||||||||||||||||||||||||
主題領域 | MICROBIOLOGY | ||||||||||||||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||||||||||||||
發行頻率 | |||||||||||||||||||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||||||||||||||||||
每年文章數 | 644每年文章數趨勢 | ||||||||||||||||||||||||||||||||||||
黃金OA百分比 | 99.47% | ||||||||||||||||||||||||||||||||||||
OA Related Info | APC: Yes( USD2926; ) APC waiver:Check Notes Other charges: No Keywords: pathogens、bacteria、fungi、parasites、prions、viruses Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1553-7374%5BISSN%5D | ||||||||||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Very fast, 2-3 Week(s) | ||||||||||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Difficult | ||||||||||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 2 3 下一頁 末頁 (頁 | |
[PLoS Pathogens] 的評論 | 撰寫評論 |
作者: VIVI66 領域: 农林科学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-30 11:09:14 評論於 One month has passed and we are still with the editor(0) 讚! | VIVI66 |
作者: 梦雨小哥哥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-01 22:19:13 評論於 It's been a month with the editor, what's going on?(0) 讚! | 梦雨小哥哥 |
作者: 矢泽语枫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-14 18:00:34 評論於 Update, submitted today, with editor on October 20th – under review until November 14th, fingers crossed for a smooth review process(0) 讚! | 矢泽语枫 |
作者: 矢泽语枫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-08 20:07:01 評論於 Hello, may I ask if there has been any progress on your article? My article has been submitted for 22 days and has been with the editor for 14 working days without being sent for review(0) 讚! | 矢泽语枫 |
作者: 一条小威威 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-25 18:45:13 評論於 How long will it be under review?(0) 讚! | 一条小威威 |
作者: 一条小威威 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-22 09:33:19 評論於 It has been two weeks with the editor, how long does this stage usually take?(0) 讚! | 一条小威威 |
作者: 天际慧丽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-10 19:04:41 評論於 How long before there is a change in status? Has it been accepted yet?(0) 讚! | 天际慧丽 |
作者: 悦弘mio 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-09 10:56:30 評論於 It's been 13 days since we heard from the editor, what's going on?(0) 讚! | 悦弘mio |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 21:53:33 評論於 Sufficient experimental data results and well-written articles(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 17:17:44 評論於 Please ask the advisor to help evaluate based on your own experimental results and the writing of the article(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 15:48:46 評論於 How much would you rate my article?(0) 讚! | 平原文波 |
作者: 破戒阳平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 17:17:38 評論於 What preparations are needed for outdoor activities?(0) 讚! | 破戒阳平 |
作者: 逸龙小哥哥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-02 16:17:33 評論於 The result of the initial review that was submitted on 4.21 came back on 5.25(0) 讚! | 逸龙小哥哥 |
作者: 逸龙小哥哥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-02 14:27:23 評論於 Yes, I waited for a month and now it has been accepted. Good luck!(0) 讚! | 逸龙小哥哥 |
作者: 长安成双 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-10-28 14:14:51 評論於 It takes a month for the first-instance trial to reply?(0) 讚! | 长安成双 |
作者: 长安成双 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-10-28 12:17:16 評論於 I have been waiting for the review for 16 days already. When can I expect a reply from you?(0) 讚! | 长安成双 |
作者: 逸龙小哥哥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-09-11 21:52:45 評論於 Review speed: 1.0 | Submission acceptance rate: 25.0 | Layout fee: 2575.0 Research focus: Innate immunity Experience sharing: The review is very professional, really very professional, and carefully reviews the paper(0) 讚! | 逸龙小哥哥 |
作者: 逸龙小哥哥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-03 20:27:35 評論於 How long does it take for the second trial to review? It's been 6 days and still no news(0) 讚! | 逸龙小哥哥 |
作者: 文静少爷 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-03-02 08:53:59 評論於 To wnj1738555_28787312, why do you always focus on personal evaluations? Just evaluate the journals, everyone has their own opinions and the right to express them. Besides, I am not fabricating things, I have my own standards. You can express your own opinions here, there is no need to force others to agree with you! Just submit to the journal you like, maybe other friends will agree with my point of view!(0) 讚! | 文静少爷 |
作者: 留云鸿彩 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-01-18 17:40:28 評論於 The quality of the article on viruses in mBio is quite good!(0) 讚! | 留云鸿彩 |
作者: Herman Zephaniah 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-12-22 17:59:59 評論於 Review speed: 3.0 | Page fee: 2300.0 Emphasized research direction: Medicine; Virus experience sharing: There is still a gap in quality between mBio and PLOS Pathogens. Don't listen to the brainless sprayers on this forum. Look at how many of the top ten advances in microbiology are published in PLOS Pathogens every year. One third, the other two thirds are in NS, PNAS. It seems that mBio doesn't have a single one. Elife is posting everywhere to criticize PLOS Pathogens. How many times has it been rejected?(0) 讚! | Herman Zephaniah |
作者: 文静少爷 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-08-24 22:57:51 評論於 Publisher: The non-profit open access publisher based in San Francisco, United States, has released its latest financial data, revealing a revenue of $32 million in 2018, with a loss of $5.5 million. To cover this loss, it not only will deplete its savings, but also sell nearly $5 million in financial assets. This is not the first time PLOS has spent more than its revenue. The last time PLOS made a surplus was in 2015, when its bank balance had $30.6 million in savings. By 2017, PLOS's savings had decreased by nearly half, to $17 million, and further declined to $11 million in 2018. Meanwhile, despite the report being released, salaries and other staff benefits increased by $1.8 million (8%) in 2018 compared to 2017. The number of papers published decreased by 11%. At this rate of depletion, the publisher will run out of savings in a few years unless there is a significant change. Journals: All of PLOS journals are basically declining. Here focus on 1) PLOS Biology, the flagship journal of PLOS, a first batch Nature Index journal, but the impact factor has been continuously declining in recent years, accompanied by a slight increase in the number of publications. It should be between 6-7 next year following this trend, and it is likely to be removed from the Nature Index journal list in the near future! It is worth noting that PLOS Biology can accept articles from other journals published within six months, which is still commendable. 2) PLOS Pathogens, the impact factor is also declining year by year, and the number of publications has been decreasing in recent years, but it seems that it has limited effect, the impact factor next year will be around 5.5! The flagship journal of the American Society for Microbiology, mBio, has already surpassed PLOS Pathogens in terms of impact factor and number of publications. Based on the influence and appeal of the American Society for Microbiology, it is impossible for PLOS Pathogens to surpass mBio in the future!(0) 讚! | 文静少爷 |
作者: 坂田慈心 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-08-10 18:16:48 評論於 How long has your manuscript been submitted? What is the current status?(0) 讚! | 坂田慈心 |
作者: Michael Swift 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-08-02 16:52:25 評論於 How long after you reinvest do you receive it?(0) 讚! | Michael Swift |
作者: 万花海凡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-06-01 20:08:19 評論於 Review speed: 1.0 Experience sharing: Sending out for review generally takes about a month. Given two months for major revisions, didn't have time, so applied for an extra month. Accepted within 2 days after revisions(0) 讚! | 万花海凡 |
首頁 上一頁 1 2 3 下一頁 末頁 (頁 |
Contact us